The combination of Illumina's Single Cell Prep, NovaSeqâ„¢ X Plus platform, 25B flow cell and DRAGENâ„¢ analysis software creates a seamless end-to-end workflow enabling the high-throughput ...
Illumina will seek to cut $100 million in expenses by the end of this fiscal year as it plans to deal with a loss of revenue ...
18d
Zacks Investment Research on MSNILMN Stock Might Rise From Collaboration With Broad Clinical LabsIllumina, Inc. ILMN recently entered into a collaboration with Broad Clinical Labs to rapidly streamline and scale single-cell projects with cutting-edge tools and workflows. Together, the companies ...
For end users wishing to use an Illumina sequencing system, dedicated flow cells and reagents from Illumina are required to complete the sequencing process, and most of Illumina’s consumables ...
Illumina, Inc. (NASDAQ ... delivering the NovaSeq X single-flow-cell system alongside a cutting-edge software upgrade and new kits.
Illumina's technology suite, including the NovaSeqâ„¢ X Plus platform, 25B flow cell, and DRAGENâ„¢ analysis software, is designed to create an efficient end-to-end workflow for high-throughput ...
Illumina (ILMN) responded to the March 4 notice from the China Ministry of Commerce that the company is not permitted to export sequencing ...
6mon
Zacks.com on MSNBull of the Day: Illumina (ILMN)It operates through Core Illumina and GRAIL segments. The company offers sequencing and array-based instruments and ...
The integration of cutting-edge technologies is set to support the research community in undertaking billion-cell atlas studies, paving the way for new discoveries. Illumina's technology suite, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results